Skip to main content
. 2016 Jul 12;11(7):e0157323. doi: 10.1371/journal.pone.0157323

Fig 2. Quality adjusted life years as a function of Hb treatment targets illustrates an inverted U-shaped relationship in persons with CKD stages 3–4.

Fig 2

ESA, erythropoietin stimulating agents; Hb, hemoglobin.